| __timestamp | Amicus Therapeutics, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 23138050 |
| Thursday, January 1, 2015 | 76943000 | 57410147 |
| Friday, January 1, 2016 | 104793000 | 41454452 |
| Sunday, January 1, 2017 | 149310000 | 31690298 |
| Monday, January 1, 2018 | 270902000 | 52968505 |
| Tuesday, January 1, 2019 | 286378000 | 81048686 |
| Wednesday, January 1, 2020 | 308443000 | 128874979 |
| Friday, January 1, 2021 | 272049000 | 206342000 |
| Saturday, January 1, 2022 | 276677000 | 297307000 |
| Sunday, January 1, 2023 | 152381000 | 353188000 |
| Monday, January 1, 2024 | 505870000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and maintaining a competitive edge. Over the past decade, Amicus Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D spending.
From 2014 to 2023, Amicus Therapeutics increased its R&D expenses by over 220%, peaking in 2020. However, a notable decline of nearly 50% was observed in 2023, indicating potential strategic shifts or financial constraints. In contrast, Arrowhead Pharmaceuticals exhibited a consistent upward trend, with a remarkable 15-fold increase in R&D spending from 2014 to 2023. This surge underscores Arrowhead's commitment to innovation and expansion in the biotech sector.
The data highlights the dynamic nature of R&D investments and their pivotal role in shaping the future of biotechnology.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Amicus Therapeutics, Inc.
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and MannKind Corporation